BFRG
BullFrog AI Holdings, Inc.
Company overview
- Market capitalization
- $12.17M
- Employees
- 9
- Latest publication
- 2026-09-29
About BullFrog AI Holdings, Inc.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 215,385USD | 0USD | 0USD | 83,413USD | 33,257USD | 0USD | 1,724USD | 0USD |
| Cost Of Revenue | 108,486USD | 431USD | 431USD | 68,043USD | 26,735USD | 431USD | 862USD | 431USD |
| Gross Profit | 106,899USD | -431USD | -431USD | 15,370USD | 6,522USD | -431USD | 862USD | -431USD |
| Research Development | 339,456USD | 434,819USD | 397,189USD | 345,992USD | 480,297USD | 576,260USD | 590,856USD | 566,584USD |
| Selling General Administrative | 1,186,504USD | 1,179,808USD | 1,101,471USD | 1,239,061USD | 995,898USD | 1,480,360USD | 1,177,905USD | 1,253,357USD |
| General And Administrative Expenses | 1,186,504USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 1,525,960USD | 1,614,627USD | 1,498,660USD | 1,585,053USD | 1,476,195USD | 2,056,620USD | 1,768,761USD | 1,819,941USD |
| Operating Income | -1,419,061USD | -1,614,627USD | -1,498,660USD | -1,569,683USD | -1,469,673USD | -2,056,620USD | -1,768,761USD | -1,819,941USD |
| Total Other Income Expense Net | 47,531USD | 21,466USD | 18,486USD | 18,071USD | 20,944USD | 39,067USD | 54,018USD | 56,477USD |
| Interest Income | 49,904USD | 16,389USD | 19,108USD | 19,614USD | 23,393USD | 40,082USD | — | 61,455USD |
| Interest Expense | 2,373USD | 982USD | 622USD | 1,543USD | 2,449USD | 1,015USD | 2,008USD | 4,978USD |
| Net Income | -1,371,530USD | -1,593,161USD | -1,480,174USD | -1,551,612USD | -1,448,729USD | -2,017,553USD | -1,714,743USD | -1,763,464USD |
| Net Interest Income | — | 15,407USD | 18,486USD | 18,071USD | 20,944USD | 39,067USD | 258,886USD | -4,978USD |
| Income Before Tax | — | -1,593,161USD | -1,480,174USD | -1,551,612USD | -1,448,729USD | -2,017,553USD | -1,714,743USD | -1,763,464USD |
| Net Income From Continuing Ops | — | -1,593,161USD | -1,480,174USD | -1,551,612USD | -1,448,729USD | -2,017,553USD | -1,714,743USD | -1,763,464USD |
| Ebit | — | -1,615,058USD | -1,479,552USD | -1,550,069USD | -1,446,280USD | -2,016,538USD | -1,712,735USD | -1,758,486USD |
| Ebitda | — | -1,614,627USD | -1,479,121USD | -1,549,638USD | -1,445,848USD | -2,016,107USD | -1,712,304USD | -1,758,055USD |
| Depreciation And Amortization | — | 431USD | 431USD | 431USD | 432USD | 431USD | 431USD | 431USD |
| Reconciled Depreciation | — | 431USD | 431USD | 431USD | 432USD | 431USD | 431USD | 431USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 862USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 116,670USD | 0USD | 65,000USD | 10,000USD | 0USD | 0USD |
| Cost Of Revenue | 96,503USD | 1,724USD | 5,200USD | 800USD | 0USD | 0USD |
| Gross Profit | 20,167USD | -1,724USD | 59,800USD | 9,200USD | 0USD | 0USD |
| Research Development | 1,799,738,000,000USD | 2,223,265USD | 1,432,614USD | 609,270USD | 25,000USD | — |
| Selling General Administrative | 4,816,790,000,000USD | 5,013,118USD | 3,994,710USD | 1,855,731USD | 555,362USD | 347,193USD |
| Unclassified Operating Expenses | -6,616,521,385,197USD | — | — | — | — | — |
| Total Operating Expenses | 6,614,803USD | 7,236,383USD | 5,427,324USD | 2,465,000USD | 555,362USD | 347,193USD |
| Operating Income | -6,594,636USD | -7,236,383USD | -5,367,524USD | -2,455,801USD | -555,362USD | -347,193USD |
| Interest Income | 102,197USD | 260,894USD | 183,703USD | 459USD | — | — |
| Interest Expense | 5,629USD | 18,158USD | 79,089USD | 347,145USD | 40,395USD | 11,767USD |
| Net Interest Income | 96,568USD | 242,736USD | -189,357USD | -347,145USD | -40,395USD | -11,767USD |
| Income Before Tax | -6,498,068USD | -6,993,647USD | -5,355,869USD | -2,802,487USD | -585,840USD | -341,690USD |
| Net Income | -6,498,068USD | -6,993,647USD | -5,355,869USD | -2,802,487USD | -585,840USD | -341,690USD |
| Net Income From Continuing Ops | -6,498,068USD | -6,993,647USD | -4,754,441USD | -2,802,487USD | -585,840USD | -341,690USD |
| Ebit | -6,594,636USD | -6,975,489USD | -5,276,780USD | -2,455,342USD | -555,362USD | -347,193USD |
| Ebitda | -6,592,911USD | -6,973,765USD | -5,275,055USD | -2,454,297USD | -555,362USD | -347,193USD |
| Depreciation And Amortization | 1,725USD | 1,724USD | 1,725USD | 1,045USD | 236,558USD | 206,297USD |
| Reconciled Depreciation | 1,725USD | 1,724USD | 1,734USD | 1,045USD | 0USD | — |
| Total Other Income Expense Net | 96,568USD | 242,736USD | 11,655USD | -346,686USD | 9,917USD | 17,270USD |
| Income Tax Expense | — | -44,985USD | -5USD | 347,604USD | -196,163USD | -194,530USD |
| Selling And Marketing Expenses | — | — | 1,725USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | -585,840USD | -341,690USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 7,693,852USD | 5,538,863USD | 2,808,655USD | 2,702,356USD | 2,869,194USD | 4,085,872USD | 5,551,830USD | 4,602,206USD |
| Cash And Equivalents | 6,918,141USD | — | — | — | — | — | — | — |
| Long Term Investments | 116,670USD | 116,670USD | 116,670USD | 58,335USD | 58,335USD | — | 0USD | — |
| Total Current Assets | 7,470,520USD | 5,315,099USD | 2,584,156USD | 2,536,065USD | 2,702,472USD | 4,082,054USD | 5,547,580USD | 4,597,525USD |
| Other Current Assets | 336,994USD | 234,636USD | 400,451USD | 487,018USD | 228,837USD | 280,126USD | 111,597USD | 358,537USD |
| Total Liabilities | 706,590USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 706,590USD | 652,072USD | 672,022USD | 758,701USD | 681,084USD | 839,397USD | 588,090USD | 779,037USD |
| Other Current Liabilities | 90,138USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 6,987,262USD | 4,886,791USD | 2,136,329USD | 1,943,655USD | 2,188,110USD | 3,246,475USD | 4,963,740USD | 3,823,169USD |
| Total Equity Including Noncontrolling Interest | 6,987,262USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,662USD | 2,094USD | 2,525USD | 2,956USD | 3,387USD | 3,818USD | 4,250USD | 4,681USD |
| Accounts Payable | 169,945USD | 216,986USD | 168,151USD | 168,212USD | 181,793USD | 210,533USD | 435,934USD | 91,374USD |
| Common Stock | 185USD | 184USD | 114USD | 104USD | 96USD | 94USD | 91USD | 79USD |
| Retained Earnings | -26,256,315USD | -24,884,785USD | -23,291,624USD | -21,811,450USD | -20,259,838USD | -18,811,109USD | -16,793,556USD | -15,050,602USD |
| Total Liab | — | 652,072USD | 672,326USD | 758,701USD | 681,084USD | 839,397USD | 588,090USD | 779,037USD |
| Other Current Liab | — | 435,086USD | 503,871USD | 534,883USD | 363,922USD | 464,794USD | 152,156USD | 515,658USD |
| Capital Stock | — | 185USD | 115USD | 105USD | 97USD | 95USD | 92USD | 80USD |
| Cash | — | 5,080,463USD | 2,183,705USD | 1,990,712USD | 2,473,635USD | 3,801,928USD | 5,435,983USD | 4,238,988USD |
| Cash And Short Term Investments | — | 5,080,463USD | 2,183,705USD | 1,990,712USD | 2,473,635USD | 3,801,928USD | 5,435,983USD | 4,238,988USD |
| Net Debt | — | -5,080,463USD | -2,183,705USD | -1,935,106USD | -2,363,344USD | -3,637,858USD | -5,435,983USD | -4,066,983USD |
| Short Long Term Debt | — | 133,886USD | — | 55,606USD | 110,291USD | 164,070USD | — | 172,005USD |
| Common Stock Shares Outstanding | — | 12,948,732shares | 11,418,183shares | 10,379,775shares | 9,706,356shares | 9,689,812shares | 8,245,353shares | 8,124,834shares |
| Non Current Assets Total | — | 223,764USD | 224,498USD | 166,291USD | 166,722USD | 3,818USD | 4,249USD | 4,681USD |
| Non Current Liabilities Total | — | 0USD | 304USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 105,000USD | 105,000USD | 105,000USD | 105,000USD | — | 0USD | — |
| Net Working Capital | — | 4,663,027USD | 1,912,134USD | 1,777,364USD | 2,021,388USD | 3,242,657USD | 4,959,490USD | 3,818,488USD |
| Unclassified Equity | — | 29,771,207USD | 25,427,724USD | 23,754,896USD | 22,447,755USD | 22,057,395USD | 21,757,113USD | 18,873,613USD |
| Property Plant Equipment Gross | — | — | 8,744USD | — | — | — | 8,744USD | — |
| Short Term Debt | — | — | — | 55,606USD | 110,291USD | 164,070USD | — | 172,005USD |
| Short Long Term Debt Total | — | — | — | 55,606USD | 110,291USD | 164,070USD | — | 172,005USD |
| Net Receivables | — | — | — | 58,335USD | — | — | — | — |
| Current Deferred Revenue | — | — | — | — | 25,078USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | -1USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 2,808,351USD | 5,551,830USD | 2,776,586USD | 80,369USD | 10,014USD | 5,019USD |
| Other Current Assets | 400,451USD | 111,597USD | 145,882USD | 15,000USD | — | — |
| Total Liab | 672,022USD | 588,090USD | 184,350USD | 3,137,721USD | 1,019,121USD | 545,537USD |
| Total Stockholder Equity | 2,136,329USD | 4,963,740USD | 2,592,236USD | -3,057,352USD | -1,009,107USD | -540,518USD |
| Other Current Liab | 503,871USD | 152,156USD | 80,694USD | 982,988USD | 354,223USD | 241,173USD |
| Common Stock | 114USD | 91USD | 61USD | 40USD | 272USD | 252USD |
| Capital Stock | 115USD | 92USD | 62USD | 41USD | 272USD | 252USD |
| Retained Earnings | -23,291,624USD | -16,793,556USD | -9,754,924USD | -4,399,055USD | -1,596,568USD | -1,010,728USD |
| Cash | 2,183,705USD | 5,435,983USD | 2,624,730USD | 57,670USD | 10,014USD | 5,019USD |
| Cash And Short Term Investments | 2,183,705USD | 5,435,983USD | 2,624,730USD | 57,670USD | 10,014USD | 5,019USD |
| Total Current Assets | 2,584,156USD | 5,547,580USD | 2,770,612USD | 72,670USD | 10,014USD | 5,019USD |
| Total Current Liabilities | 672,022USD | 588,090USD | 184,350USD | 3,137,721USD | 1,019,121USD | 545,537USD |
| Net Debt | -2,183,705USD | -5,435,983USD | -2,624,730USD | 1,521,070USD | 576,290USD | 204,898USD |
| Long Term Investments | 116,670USD | 0USD | — | — | — | — |
| Accounts Payable | 168,151USD | 435,934USD | 103,656USD | 543,993USD | 68,594USD | 94,447USD |
| Property Plant Equipment Net | 2,525USD | 4,250USD | 5,974USD | 7,699USD | 0USD | — |
| Property Plant Equipment Gross | 8,744USD | 8,744USD | 8,744USD | 8,744USD | — | — |
| Common Stock Shares Outstanding | 10,337,000shares | 8,245,353shares | 6,049,819shares | 6,086,952shares | 5,650,419shares | 5,650,419shares |
| Non Current Assets Total | 224,195USD | 4,250USD | 5,974USD | 7,699USD | 0USD | 100USD |
| Non Current Liabilities Total | 304USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | 105,000,000,000USD | — | 0USD | — | — | 0USD |
| Net Working Capital | 1,912,134USD | 4,959,490USD | 2,586,262USD | -3,065,051USD | -1,009,107USD | -540,518USD |
| Unclassified Non Current Assets | -104,999,895,000USD | — | — | — | — | — |
| Unclassified Equity | 25,427,724USD | 21,757,113USD | 12,347,038USD | 1,341,622USD | — | — |
| Accumulated Other Comprehensive Income | — | — | -1USD | — | — | — |
| Current Deferred Revenue | — | — | — | 32,000USD | 10,000USD | — |
| Short Term Debt | — | — | — | 1,578,740USD | 586,304USD | 209,917USD |
| Short Long Term Debt | — | — | — | 1,578,740USD | 586,304USD | 209,917USD |
| Short Long Term Debt Total | — | — | — | 1,578,740USD | 586,304USD | 209,917USD |
| Unclassified Current Liabilities | — | — | — | -1,578,740USD | — | — |
| Net Tangible Assets | — | — | — | — | -1,009,107USD | -540,518USD |
| Other Assets | — | — | — | — | — | -100USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 863USD |
| Stock Based Compensation | 236,491USD |
| Change To Liabilities | -120,570USD |
| Change In Working Capital | -142,242USD |
| Operating Cash Flow | -3,207,328USD |
| Investing Cash Flow | 0USD |
| Financing Cash Flow | 7,941,764USD |
| Change In Cash | 4,734,436USD |
| End Cash Flow | 7,023,141USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,593,161USD | -1,480,174USD | -1,551,612USD | -1,448,729USD | -2,017,553USD | -1,714,743USD | -1,763,464USD | -1,611,646USD |
| Depreciation | 431USD | 431USD | 431USD | 432USD | 431USD | 431USD | 431USD | 431USD |
| Stock Based Compensation | 126,656USD | 154,208USD | 378,230USD | 177,905USD | 300,288USD | 214,279USD | 201,571USD | 192,382USD |
| Other Non Cash Items | -228,014USD | -116,670USD | 378,230USD | -242,872USD | 300,288USD | — | 210,027USD | 193,244USD |
| Change In Working Capital | -228,014USD | 257,210USD | 65,779USD | -161,581USD | -81,291USD | 227,998USD | 355,397USD | 188,318USD |
| Total Cash From Operating Activities | -1,694,088USD | -1,184,995USD | -1,107,172USD | -1,431,973USD | -1,798,125USD | -1,272,035USD | -1,206,065USD | -1,230,515USD |
| Capital Expenditures | 0USD | -5USD | -2USD | 0USD | -5USD | 0USD | -5USD | -5USD |
| Free Cash Flow | -1,694,088USD | -1,184,995USD | -1,107,170USD | -1,431,973USD | -1,798,120USD | -1,272,035USD | -1,206,065USD | -1,230,520USD |
| Net Borrowings | 133,886USD | -55,606USD | -54,685USD | -53,779USD | 164,070USD | -172,005USD | -169,035USD | — |
| Total Cash From Financing Activities | 4,590,846USD | 1,377,988USD | 624,249USD | 208,680USD | 164,070USD | 2,469,030USD | -169,035USD | -166,114USD |
| Issuance Of Capital Stock | 4,456,960USD | 1,526,140USD | 678,934USD | 262,459USD | 0USD | 2,641,035USD | 0USD | 0USD |
| Change In Cash | 2,896,758USD | 192,993USD | -482,923USD | -1,223,293USD | -1,634,055USD | 1,196,995USD | -1,375,100USD | -1,396,629USD |
| Begin Period Cash Flow | 2,288,705USD | 2,095,712USD | 2,473,635USD | 3,801,928USD | 5,435,983USD | 4,238,988USD | 5,614,088USD | 7,010,717USD |
| End Period Cash Flow | 5,185,463USD | 2,288,705USD | 1,990,712USD | 2,578,635USD | 3,801,928USD | 5,435,983USD | 4,238,988USD | 5,614,088USD |
| Other Cashflows From Financing Activities | 4,590,846USD | -92,546USD | 624,249USD | 208,680USD | 164,070USD | — | -169,035USD | — |
| Unclassified Financing Cash Flow | -4,590,846USD | — | — | — | — | — | — | — |
| Change To Account Receivables | — | — | -58,335USD | — | — | — | — | — |
| Investments | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | — | 5USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 5USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -6,498,068,000,000USD | -6,993,647USD | -5,355,869USD | -2,802,487USD | -585,840USD | -341,690USD |
| Depreciation | 1,725,000,000USD | 1,724USD | 1,725USD | 1,045USD | 0USD | — |
| Stock Based Compensation | 1,010,631,000,000USD | 943,649USD | 631,533USD | 340,152USD | 98,951USD | 87,126USD |
| Other Non Cash Items | -36,553,080,117USD | 438,025USD | 162,959USD | 413,478USD | 7,287USD | -17,270USD |
| Change In Working Capital | 80,117USD | 438,025USD | -1,441,647USD | 1,136,922USD | 97,197USD | 60,126USD |
| Total Cash From Operating Activities | -5,522,265,000,000USD | -5,610,249USD | -6,001,299USD | -910,890USD | -382,405USD | -211,708USD |
| Capital Expenditures | -5USD | 0USD | -1USD | -8,744USD | -5USD | 0USD |
| Free Cash Flow | -5,522,265,000,000USD | -5,610,249USD | -6,001,299USD | -919,634USD | -382,405USD | -211,708USD |
| Net Borrowings | 0USD | 0USD | -219,950USD | 967,290USD | 387,300USD | 209,917USD |
| Total Cash From Financing Activities | 2,374,987,000,000USD | 8,421,502USD | 8,568,359USD | 967,290USD | 387,400USD | 209,942USD |
| Issuance Of Capital Stock | 2,467,533USD | 8,315,686USD | 7,293,651USD | 0USD | — | — |
| Change In Cash | -3,147,278,000,000USD | 2,811,253USD | 2,567,060USD | 47,656USD | 4,995USD | -1,766USD |
| Begin Period Cash Flow | 5,435,983,000,000USD | 2,624,730USD | 57,670USD | 10,014USD | 5,019USD | 6,785USD |
| End Period Cash Flow | 2,288,705,000,000USD | 5,435,983USD | 2,624,730USD | 57,670USD | 10,014USD | 5,019USD |
| Other Cashflows From Financing Activities | 2,374,984,625,013USD | 105,816USD | 1,494,658USD | -8,744USD | 100USD | 25USD |
| Investments | — | 0USD | 0USD | -8,744USD | 0USD | — |
| Total Cashflows From Investing Activities | — | — | — | -8,744USD | — | — |
| Change To Liabilities | — | — | — | — | -15,853USD | 60,126USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.